News Release

Zogenix to Release Third Quarter 2015 Financial Results and Host Conference Call & Webcast on November 9


SAN DIEGO, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that it will report its financial results for the third quarter ended September 30, 2015 after the market close, and will host a corporate update conference call and webcast on Monday, November 9, 2015, at 4:30pm Eastern Time.

Monday, November 9th @ 4:30pm Eastern Time/1:30pm Pacific Time
Toll Free: 888-523-1228
International: 719-325-2308
Conference ID: 660434
Replays, available through November 23, 2015:
Domestic: 877-870-5176
International: 858-384-5517
Conference ID: 660434

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

For more information, visit

CONTACT: Investors: Andrew McDonald
         Founding Partner, LifeSci Advisors LLC
         646-597-6987 |
Zogenix, Inc.